LURBINECTEDIN IS SAFE AND ACTIVE IN RELAPSED SMALL-CELL LUNG CANCER

被引：1
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2020年 / 10卷 / 06期
关键词：
D O I：
10.1158/2159-8290.cd-rw2020-053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：757 / 757
页数：1
相关论文
共 50 条
  • [31] Small-cell lung cancer
    Charles M. Rudin
    Elisabeth Brambilla
    Corinne Faivre-Finn
    Julien Sage
    Nature Reviews Disease Primers, 7
  • [32] Small-cell lung cancer
    van Meerbeeck, Jan P.
    Fennell, Dean A.
    De Ruysscher, Dirk K. M.
    LANCET, 2011, 378 (9804): : 1741 - 1755
  • [33] Small-cell lung cancer
    Rudin, Charles M.
    Brambilla, Elisabeth
    Faivre-Finn, Corinne
    Sage, Julien
    NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
  • [34] Treatment of Small Cell Lung Cancer with Lurbinectedin: A Review
    Rajput, Prince Singh
    Khan, Sharib Raza
    Singh, Preeti
    Chawla, Pooja A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (05) : 812 - 820
  • [35] EMERGE 402: Real-world Characteristics and Safety of Lurbinectedin in Small-cell Lung Cancer (SCLC)
    Schreeder, D.
    Badin, F.
    Dakhil, S.
    Lammers, P.
    Patel, M.
    Slater, D.
    Migas, J.
    Naveh, N.
    Boccuti, A.
    Hanvesakul, R.
    Li, W.
    Halmos, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E43 - E43
  • [36] NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC)
    Cavina, Raffaele
    Gregorc, Vanesa
    Novello, Silvia
    Grossi, Francesco
    Santoro, Armando
    Vigano, Maria Grazia
    Levra, Matteo G.
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Treatment of relapsed small-cell lung cancer - a focus on the evolving role of topotecan
    Lima, CMR
    Chiappori, A
    LUNG CANCER, 2003, 40 (03) : 229 - 236
  • [38] Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumonias
    Saijo, Atsuro
    Hanibuchi, Masaki
    Ogino, Hirokazu
    Otsuka, Kenji
    Goto, Hisatsugu
    Nokihara, Hiroshi
    Nishioka, Yasuhiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (05) : 541 - 546
  • [39] Relevance of Platinum Sensitivity in Patients with Relapsed or Refractory Small-Cell Lung Cancer
    Kim, Young Hak
    Mishima, Michiaki
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (05) : E35 - E35
  • [40] Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer
    Masuda, N
    Matsui, K
    Negoro, S
    Takifuji, N
    Takeda, K
    Yana, T
    Kobayashi, M
    Hirashima, T
    Kusunoki, Y
    Ushijima, S
    Kawase, I
    Tada, T
    Sawaguchi, H
    Fukuoka, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3329 - 3334
12345